Regulation of stromal proliferation, growth arrest, differentiation and apoptosis in benign prostatic hyperplasia by TGF-beta

scientific article

Regulation of stromal proliferation, growth arrest, differentiation and apoptosis in benign prostatic hyperplasia by TGF-beta is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.2741/1093
P698PubMed publication ID12957826
P5875ResearchGate publication ID10580700

P2093author name stringChung Lee
Xuemei Huang
P921main subjectapoptotic processQ14599311
prostatic hypertrophyQ506659
P304page(s)s740-9
P577publication date2003-09-01
P1433published inFrontiers in BioscienceQ5506062
P1476titleRegulation of stromal proliferation, growth arrest, differentiation and apoptosis in benign prostatic hyperplasia by TGF-beta
P478volume8

Reverse relations

cites work (P2860)
Q37115315A role for epithelial-mesenchymal transition in the etiology of benign prostatic hyperplasia
Q57213602Administration of extract of mushroom Phellinus linteus induces prostate enlargement with increase in stromal component in experimentally developed rat model of benign prostatic hyperplasia
Q34485215CXC-type chemokines promote myofibroblast phenoconversion and prostatic fibrosis
Q90226597Can Botulinum Toxin A Still Have a Role in Treatment of Lower Urinary Tract Symptoms/Benign Prostatic Hyperplasia Through Inhibition of Chronic Prostatic Inflammation?
Q64068522Effect of gold nanoparticles treatment on the testosterone-induced benign prostatic hyperplasia in rats
Q61167608Elevated neutrophil elastase and acrolein-protein adducts are associated with W256 regression
Q37376875Endocrine-immune-paracrine interactions in prostate cells as targeted by phytomedicines
Q38628753Epithelial-mesenchymal transition in prostatic disease
Q39013561Evidence of TGF-β1 mediated epithelial-mesenchymal transition in immortalized benign prostatic hyperplasia cells
Q51008917Fibrillar collagen genes are not coordinately upregulated with TGF β1 expression in finasteride-treated prostate.
Q46930324Growth factor, cytokine, and vitamin D receptor polymorphisms and risk of benign prostatic hyperplasia in a community-based cohort of men.
Q92617057Hypoxia-inducible factor 1α (HIF-1α) mediates the epithelial-mesenchymal transition in benign prostatic hyperplasia
Q64287632Immunohistochemical Expression of E- and N-Cadherin in Nodular Prostatic Hyperplasia and Prostatic Carcinoma
Q33960272Increased CK5/CK8-positive intermediate cells with stromal smooth muscle cell atrophy in the mice lacking prostate epithelial androgen receptor
Q37338238Is transforming growth factor-β signaling activated in human hypertrophied prostate treated by 5-alpha reductase inhibitor?
Q92668881Kangquan Recipe Regulates the Expression of BAMBI Protein via the TGF-β/Smad Signaling Pathway to Inhibit Benign Prostatic Hyperplasia in Rats
Q30425035Low-power GaAlAs laser irradiation promotes the proliferation and osteogenic differentiation of stem cells via IGF1 and BMP2
Q84346626Mechanisms of prostate atrophy after LHRH antagonist cetrorelix injection: an experimental study in a rat model of benign prostatic hyperplasia
Q38077302Non-steroidal anti-inflammatory drugs for lower urinary tract symptoms in benign prostatic hyperplasia: systematic review and meta-analysis of randomized controlled trials
Q37364472Promising molecular targets and biomarkers for male BPH and LUTS
Q55302098Specific expression pattern of tissue cytokines analyzed through the Surface Acoustic Wave technique is associated with age-related spontaneous benign prostatic hyperplasia in rats.
Q33416979Stromal nodules in benign prostatic hyperplasia: morphologic and immunohistochemical characteristics
Q36279487Targeting androgen receptor to suppress macrophage-induced EMT and benign prostatic hyperplasia (BPH) development
Q37207618Targeting stromal androgen receptor suppresses prolactin-driven benign prostatic hyperplasia (BPH).
Q38238738The role of interleukin 17 in tumour proliferation, angiogenesis, and metastasis.
Q42476964Transforming growth factor β-receptor II protein expression in benign prostatic hyperplasia is associated with prostate volume and inflammation
Q37419153Tropomyosin Receptor Kinase C Targeted Delivery of a Peptidomimetic Ligand-Photosensitizer Conjugate Induces Antitumor Immune Responses Following Photodynamic Therapy
Q37781690Up for Mischief? IL-17/Th17 in the tumour microenvironment

Search more.